Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-004543

10% owner bought 17,500 shares at an average $4.45 ($77,900)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-02-10 Purchase +5,000 $4.58 $22,900 5,163,286 D: show line 1 in the form
Cambrian BioPharma Inc 10% owner 2022-02-11 Purchase +12,500 $4.40 $55,000 5,175,786 D: show line 2 in the form
Open-market purchases · 17,500 sh · avg $4.45 · $77,900
Loading xslF345X03/doc1.xml…